M. Cazzola (Rome, Italy), C. F. Donner (Borgomanero, Italy)
LATE-BREAKING ABSTRACT: The level of markers of endothelial dysfunction in men with chronic obstructive pulmonary disease and osteopenic syndrome
E. Kochetkova, L. Ugay, Y. Maistrovskaya, V. Nevzorova (Vladivostok, Russian Federation; Strasbourg, France)
|   |
Patient-reported outcomes as predictors of COPD exacerbations - a prospective study
A. Strassmann, A. Frei, L. Siebeling, P. Muggensturm, M. Zoller, G. ter Riet, M. Puhan (Zurich, Switzerland; Amsterdam, Netherlands)
| |
Comparison of diagnostic value of patient health questionnaire 9 (PHQ-9) and Beck depression inventory (BDI) questionnaire for preliminary diagnosing of depression in COPD patients (pts)
Y. Huba, L. Konopkina, T. Pertseva (Dnipropetrovs'k, Ukraine)
| |
Prescribing patterns for UK patients commencing first maintenance therapy for COPD
D. Price, K. Bichel, D. West, V. L. Ashton, R. Stewart (Aberdeen, Cambridge, United Kingdom)
| |
Effects of nebivolol and ivabradine on the left ventricular diastolic function in patients (pts) with COPD and stable angina
O. Fesenko, T. Pertseva (Dnipropetrovsk, Ukraine)
| |
Effects of aclidinium bromide/formoterol fumarate fixed-dose combination on health status in COPD
P. Jones, S. Korn, P. D. Scanlon, D. Singh, V. Mergel, E. Molins, A. Leselbaum (London, Manchester, United Kingdom; Mainz, Germany; Rochester, Jersey City, United States Of America; Barcelona, Spain)
| |
Factors associated with cognitive dysfunction in COPD patients hospitalised with exacerbations
A. Tappouni, M. Bajaj, M. Tumilty, J. Dodd, P. Jones, E. Baker (London, Bristol, United Kingdom)
| |
The availibility of copd assessment test (CAT) in determination of risk of early hospitalization in chronic obstructive pulmonary disease patients and its correlation with pulmonary function tests, dyspnea measurement scales and St George respiratory questionnaire
M. Dinç, E. Maden, K. Uzun (Van, Konya, Turkey)
| |
Pulmonary diffusing capacity and the risk of fractures in patients with chronic obstructive pulmonary disease (COPD)
E. Kochetova (Petrozavodsk, Russian Federation)
| |
Acute myocardial infarction among Spanish adults with and without COPD: Cumulative incidence and outcomes
J. de Miguel Díez, R. Jiménez García, A. Oliva Ramos, V. Hernández Barrera, A. López de Andrés, M. Llanos Flores, I. Jarana Aparicio, J. C. Vargas Espinal, L. Puente Maestu, P. Carrasco Garrido (Madrid, Alcorcón, Spain)
| |
Number of exacerbations in COPD patients treated with nasal high flow heated and humidified oxygen
L. Storgaard, M. Frystyk, H. Hockey, U. M. Weinreich (Aalborg, Denmark; Hamilton, New Zealand)
| |
Bacterial resistance induction with prophylactic antibiotics in COPD
S. Brill, M. Law, J. Allinson, E. El-Emir, T. McHugh, G. Donaldson, D. Jackson, M. Sweeting, W. Wedzicha (London, Cambridge, United Kingdom)
| |
The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD)
V. Saienko, L. Konopkina (Dnipropetrovs'k, Ukraine)
| |
Response to the combined therapy in COPD patients (pts) with different plasma surfactant protein D (SPD) level
T. Pertseva, K. Gashynova (Dnipropetrovsk, Ukraine)
| |
Infective exacerbations of COPD. Relation between the bacteriologic etiology and severity of the disease
A. Ben Saad, N. Rouatbi, N. Skhiri, S. Joobeur, H. Mribah, S. Cheikh Mhamed, A. El Kamel (Monastir, Tunisia)
| |
Impact of lung function impairment and exacerbation history on COPD patient-reported utility
M. Miravitlles, A. Huerta, F. García-Río, A. Fernández-Villar, B. Alcázar, C. Forné, M. Cuesta, M. Brosa (Barcelone, Madrid, Vigo, Loja (Granada), Spain)
| |
What are common COPD symptoms in a real-life setting? The German DACCORD registry
R. Buhl, C. P. Criée, P. Kardos, C. Vogelmeier, H. Worth (Mainz, Bovenden, Frankfurt am Main, Marburg, Fuerth, Germany)
| |